The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes
The July 2016 issue of Diabetes Care presents the current state of the artificial pancreas, including important reports on multinational home-use artificial pancreas trials, studies in young children, the use of multihormonal approaches to mitigate meal-related hyperglycemia, and discussions of artificial pancreas study designs and outcome measures. This collection of articles establishes the artificial pancreas as a new diabetes treatment paradigm—not a single-function CGM or CSII device but an adaptable wearable network encompassing the patient in a digital treatment ecosystem.
Original Article Multinational Home Use of Closed-Loop Control Is Safe and Effective
Stacey M. Anderson, Dan Raghinaru, Jordan E. Pinsker,Federico Boscari, Eric Renard, Bruce A. Buckingham,Revital Nimri, Francis J. Doyle, Sue A. Brown, PatrickKeith-Hynes, Marc D. Breton, Daniel Chernavvsky, Wendy C. Bevier, Paige K. Bradley, Daniela Bruttomesso, SimoneDel Favero, Roberta Calore, Claudio Cobelli, AngeloAvogaro, Anne Farret, Jerome Place, Trang T. Ly, SatyaShanmugham, Moshe Phillip, Eyal Dassau, Isuru S.Dasanayake, Craig Kollman, John W. Lum, Roy W. Beck,Boris Kovatchev, for the Control to Range Study Group
Diabetes Care 2016 Jul; 39 (7): 1143-1150. http://dx.doi.org/10.2337/dc15-2468